A breakthrough study from Vrije Universiteit Brussel (VUB) is redefining how clinicians identify and mitigate the risk of brain damage in premature infants, shifting the diagnostic focus from blood supply to blood drainage.
For nearly five decades, neonatal care has primarily relied on monitoring the arteries to assess the health of a premature baby’s brain. However, new research led by paediatrician and neonatologist Dr. Fleur Camfferman of VUB and UZ Brussel suggests that this traditional approach often misses critical danger signs. The study reveals that the real indicator of risk lies in the veins—the vessels responsible for draining blood away from the brain.
An Early Warning System for Neonatal Care
The vulnerability is particularly acute for infants born before 32 weeks. At this stage of development, the brain is still forming, and its blood vessels are exceptionally thin and fragile. Even minor fluctuations in pressure can lead to hemorrhaging.
Dr. Camfferman describes the mechanism using a simple analogy: “It’s like a drainpipe that can’t take the pressure.” According to the research, by analyzing the flow of the veins, doctors can determine if the brain is under distress. When blood cannot flow out easily, internal pressure builds, increasing the likelihood that fragile vessels will burst.
This discovery effectively creates an early warning system, allowing medical teams to identify at-risk infants much faster than previously possible.
Moving Toward Personalized Medicine
The implications of this research extend beyond diagnosis, signaling a move toward more personalized neonatal intervention. Historically, most premature babies have received standardized treatments based on general metrics, such as birth date or weight.
Dr. Camfferman’s findings argue for a tailored approach. By utilizing ultrasound to confirm whether blood flow remains stable, physicians can make more informed decisions about whether specific treatments—which can carry their own drawbacks—are actually necessary for a particular patient.
This shift toward precision diagnostics highlights a broader trend in medical innovation, where real-time physiological data is used to replace one-size-fits-all protocols, potentially reducing unnecessary interventions and improving long-term outcomes for the smallest patients.
For more information on the institution’s work, visit VUB Brussels University.
